SCHEMBL4627016

SCHEMBL4627016

CN1CCN(C(=O)COc2ccc(Cl)cc2Cc2cc(Cl)ccc2OCC(=O)O)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.59
PTGDR2 Q9Y5Y4 2/20 0.58
SMN1; SMN2 Q16637 5/20 0.57
LMNA P02545 5/20 0.57
HTT P42858 2/20 0.57
GAA P10253 2/20 0.57
MAPK1 P28482 2/20 0.57
ALOX12 P18054 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
TSHR P16473 4/20 0.54
HPGD P15428 3/20 0.54
NPC1 O15118 1/20 0.54
MEN1 O00255 1/20 0.54
ALDH1A1 P00352 1/20 0.54
KMT2A Q03164 1/20 0.54
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C19 P33261 1/20 0.53
TDP1 Q9NUW8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2942339 0.94 PTGDR2 (0.52) MAPTPTGDR2SMN1; SMN2LMNAHTT
SCHEMBL2944820 0.85 PTGDR2 (0.52) MAPTPTGDR2SMN1; SMN2LMNAHTT
SCHEMBL2944566 0.83 SMN1; SMN2 (0.49) MAPTPTGDR2SMN1; SMN2LMNAHTT
SCHEMBL15134824 0.83 SMN1; SMN2 (0.80) MAPTSMN1; SMN2LMNAHTTGAA
SCHEMBL4628496 0.82 MAPT (0.79) MAPTPTGDR2TSHRTDP1PTGDR
SCHEMBL15134842 0.82 SMN1; SMN2 (0.83) MAPTSMN1; SMN2LMNAHTTGAA
SCHEMBL2938776 0.81 PTGDR2 (0.48) MAPTPTGDR2SMN1; SMN2LMNAHTT
SCHEMBL4626978 0.76 MAPT (0.65) MAPTPTGDR2LMNATSHRTDP1
SCHEMBL4626233 0.76 MAPT (0.68) MAPTPTGDR2TSHRTDP1PTGDR
SCHEMBL2949145 0.76 SMN1; SMN2 (0.57) MAPTPTGDR2SMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891029-A1 ORGANIC COMPOUNDS FOR THE TREATMENT OF IMFLAMMATORY OR ALLERIC CONDITIONS Novartis AG (CH) 2008-02-27 EP disclosed
WO-2006125596-A1 ORGANIC COMPOUNDS FOR THE TREATMENT OF IMFLAMMATORY OR ALLERIC CONDITIONS NOVARTIS AG (CH) 2006-11-30 WO disclosed